Risk of deep infection in joint (hip and knee) replacement: Evaluation concerning a continuous series of 1 000 cases;Évaluation du risque infectieux sur prosthèses totales de hanche et de geneou: À propos d'une série continue de 1 000 prothèses

Antibiotiques

Volumn 7, Issue 2, 2005, Pages 87-92

  Eveillard, Mathieu ^a,b   Canarelli, B ^a   Lavenne, J ^a   Eb, F ^a   Mertl, P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

Infection of surgical site; Surveillance; Total hip prostheses; Total knee prostheses

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN DERIVATIVE; ISOPENICILLIN N; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE QUALITY; HUMAN; INFECTION RISK; INFECTIOUS ARTHRITIS; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS; WOUND INFECTION;

EID: 19144366411     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1294-5501(05)80172-4     Document Type: Article

References (30)

1. Golliot F, Astagneau P, Brücker G. Surveillance of surgical-site infections: results of the INCISO 1998 Network. Ann Chir 1999; 53: 186-93.
2. The French Prevalece Survey Study Group. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. J Hosp Infect 2000; 46: 186-93.
3. Byrne DJ, Lynce W, Napier A, et al. Wound infection rates: the importance of definition and post-discharge wound surveillance. J Hosp Infect 1994; 26: 37-43.
4. Sands K, Vineyard G, Platt R. Surgical site infection occurring after hospital discharge. J Infect Dis 1996; 173: 963-70.
5. Horan TC, Gaynes RP, Marton WJ, et al. CDC definitions of nosocomial surgical site infections, 1993: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20: 271-4.
6. Vogely HC, Oner FC, Fleer A, et al. Hematogenous infection of a total hip prosthesis due to Clostridium perfringens. Clin Infect Dis 1999; 28: 157-8.
7. Gaine WJ, Ramanohan NA, Hussein NA, et al. Wound infection in hip and knee arthroplasty. J Bone Joint Surg Br 2000; 82: 561-5.
8. Dellamonica P, Lortat-Jacob A, Carsenti H, et le Groupe Tiresias. Infections sur prothèses articulaires: diagnostic, épidémiologie et prévention. Hygiènes 2003; XI: 25-36.
9. Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications: a study of consistency of ratings. J Anesthesiol 1978; 49: 239-43.
10. Bray GA. Classification and evaluation of the obesities. Med Clin North Am 1989; 73: 161-84.
11. Culver DH, Horan TC, Gaynes RP, et al. Surgical, wound infection rates by wound class, operative procedures and patient risk index. National Nosocomial Infection Surveillance System. Am J Med 1991; 91: 152S-7S.
12. Comité de l'antibiogramme de la Société Française de Microbiologie. Communiqué 1998. Path Biol 1998; 46: I-XVI.
13. Société Française d'anesthésie et de Réanimation. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie. Actualisation 1999. Méd Mal Infect 1999; 29: 435-45.
14. Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 1998; 36: 2932-9.
15. Comité Technique National des Infections Nosocomiales: Cent recommandations pour la surveillance et la prévention des infections nosocomiales; 1999.
16. Barberi EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case control study. Clin Infect Dis 1998; 27: 1247-54.
17. Bruce J, Russel EM, Mollisson J, et al. The measurement and monitoring of surgical adverse events. Health Technol Assess 2001; 5: 29-53.
18. Whitby M, Mclaws M-L, Collopy B, et al. Post-discharge surveillance: can patients reliably diagnose surgical wound infections? J Hosp Infect 2002; 52: 155-60.
19. Taylor EW, Duffy K, Lee K, et al. Telephone call contact for post-discharge surveillance of surgical site infections. A pilot, methodological study. J Hosp Infect 2003; 55: 8-13.
20. Nasser S. The incidence of sepsis after total hip arthroplasty. Seminars in Arthroplasty 1994; 5: 153-9.
21. Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin Orthop 1999; 369: 124-38.
22. Glenny AM, Song F. Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol Access 1999; 3: 1-9.
23. Bengston S, Knutson K. The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand 1991; 62: 301-11.
24. Poss R, Thornhill TS, Ewald FC, et al. Factors influencing the incidence and outcome, of infection following total joint arthroplasty. Clin Orthop 1984; 182: 117-26.
25. Johnson DP, Bannister GC. The outcome of infected arthroplasty of the knee. J Bone Joint Surg 1986; 68: 289-91.
26. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997; 79: 590-5.
27. Chiu FY, Chen CM, Lin CF, et al. Cefuroxime-impregnated cement in primary, total knee arthroplasty: a prospective randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002; 84: 759-62.
28. Chiu FY, Lin CF, Chen CM, et al. Cefuroxime-impregnated cement in primary total knee arthroplasty in diabete mellitus: a prospective randomised study. J Bone Joint Surg Br 2001; 83: 691-5.
29. Quenon J-L, Eveillard M, Vivien A, et al. Evaluation of current practices in surgical antimicrobial prophylaxis in primary-total hip prosthesis - a multicentre survey in private and public French hospitals. J Hosp Infect 2004; 56: 202-7.
30. Hénicque M, Eveillard M, Weibel B, et al. Evaluation de la préparation cutanée des patients dans un service de chirurgie. Hygiènes 2003; XI: 37-42.